At 14:28 this afternoon, Dr. Zhang Yu posted on his Weibo that he had been expelled from the Third Hospital of Peking University. According to the photo of the “Notice” affixed with the official seal of Peking University Third Hospital posted on Weibo, it shows: “From April 2021 to February 2022, due to your actions having a negative impact on the reputation of the hospital, the hospital has repeatedly As a reminder, you have not stopped your misconduct. After discussion and research by the hospital president’s office meeting and the party committee, it was decided that… from February 25, 2022, the employment of the hospital and you will be terminated… From now on, you may not use Peking University as the third Publicity or engaging in medical, academic and other related activities as a hospital employee.
Original text of Dr. Zhang Yu’s Weibo
Event Review
On April 18, 2021, the self-proclaimed medical oncologist of Peking University Third Hospital. Since the user “Dr. Zhang Yu” published a document on the platform to expose the “black story of tumor treatment”, Zhang Yu pointed out in a long article that a considerable proportion of tumor patients have spent unnecessary and expensive expenses, and a certain proportion of patients have irregular or even wrong diagnosis and treatment. And death. Zhang Yu cited a cancer patient who was empty of money and man. After being treated by Lu Wei, the deputy chief physician of the Xinhua Hospital affiliated to Shanghai Jiaotong University, the patient unfortunately passed away and owed more than 100,000 yuan in debt. The patient “costs 10 times more and died earlier” because of Lu Wei’s treatment plan, which includes abandoning the lower-cost treatment plan and switching to the “extraordinary second-line treatment plan with a sharp increase in cost” and ineffective, expensive, and illegal. Zhang Yu said such a diagnosis and treatment plan is a typical over-medical behavior.
The incident of “the doctors of the Third Hospital of Beijing Medical University reflecting the shady story of tumor treatment” aroused widespread concern in the society. Afterwards, the National Health and Medical Commission The Commission issued a relevant announcement, attaching great importance to the “unveiling event”, and immediately organized an investigation and verification of the relevant situation and the problems reported.
On April 27, the National Health and Medical Commission released “Cancer Treatment Shady” “The preliminary findings of the investigation were announced: the treatment was basically in line with the norm.
On May 24, the Shanghai Municipal Health and Health Commission announced the administrative punishment of Dr. Lu Wei, for “failure to fill in the medical records as required, and failure to fulfill the obligation of notification in the process of providing medical and health services. The punishment decision shows that Lu Wei violated the first paragraph of Article 13 of the Regulations on the Prevention and Handling of Medical Disputes and the first paragraph of Article 15 of the Regulations on the Prevention and Handling of Medical Disputes. Article 47(2) of the Regulations on Prevention and Handling and Article 47(4) of the Regulations on the Prevention and Handling of Medical Disputes shall be imposed with suspension of practice for 6 months and a warning, and a fine of RMB 3 million yuan.
On May 25th, Lu Wei’s practice hospital “Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine” was given a “warning and a fine of 40,000 yuan” by the Shanghai Health and Health Commission due to the unsound medical quality management of medical institutions. deal with.
In mid-February 2022, Dr. Zhang Yu once again posted four long articles on the self-media platform, accusing the doctor Chen Zongxiang involved in the “Liaocheng Fake Drug Case” of improper medication, and believing that Dr. Chen Zongxiang used cabozantinib Treating patients with SCLC is wrong and not supported by any literature and guidelines.
Different “tumor treatment shady”, Dr. Zhang Yu’s remarks attracted many different voices from the industry :
What is your opinion on this? Welcome to leave us a message.